IPO & Beyond

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Established in 1996, VantagePoint Capital Partners is a global venture investor with a focus on energy innovation and efficiency. With over $4 billion under management, the firm supports companies from start-up to scale-up, providing not only capital but also strategic resources, partnership alliances, and ongoing support. Headquartered in Silicon Valley, VantagePoint has offices in Beijing and strategic partners worldwide, emphasizing its commitment to energy innovation and efficiency.

Pittsburgh Life Sciences Greenhouse (PLSG) is a leading life sciences investment firm in Western Pennsylvania, dedicated to fostering innovation and commercialization in the life sciences sector. PLSG supports entrepreneurs and emerging companies by providing funding, strategic guidance, and access to resources, with a focus on improving healthcare outcomes and driving economic growth in the region. The firm is deeply connected to the growing impact of data analytics in healthcare and is committed to supporting underserved groups through initiatives like the 'Under 40, Underserved Advisory Board'.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

IU Ventures is a 501(c)(3) affiliate of Indiana University focused on advancing high potential new venture opportunities. It supports IU students, faculty, staff, and alumni in creating and growing startups that generate significant social and economic impact for Indiana University, the state of Indiana, and the world. The organization manages several investment programs, including the IU Philanthropic Venture Fund, IU Angel Network, and IU Founders & Funders Network, to foster a pervasive entrepreneurial culture and contribute to economic development.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Glynn Capital is a private and public technology investment firm focused on long-term investments in technology growth companies. The firm aims to partner with exceptional teams leveraging disruptive technologies to address markets ripe for change. Glynn Capital invests in both private early-growth stage companies and public durable growth companies, seeking to add value through experience and networks.

Triangle Angel Partners (TAP) is an angel fund based in the Research Triangle Park area of North Carolina. Formed in 2011, TAP aims to leverage the expertise and capital of its members to support local entrepreneurs in high-tech start-ups. TAP provides not only financial investment but also mentoring, counseling, and access to a vast network of potential investors, customers, and strategic partners. The firm has launched two funds, TAP I and TAP II, with a focus on investing in companies within a half-day's drive of Research Triangle Park.

Black Diamond Ventures (BDV) is a transformational venture capital firm with over two decades of experience in hybrid investing. Founded by Chris Lucas, BDV focuses on multi-stage investments in biotech, deep tech, and med tech sectors, supporting visionary founders with strategic and operational guidance. The firm is committed to building relationships among investors and their investments, helping founders reach the next level through a network of partners and strategic opportunities.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

LSG Investments is an evergreen venture fund dedicated to advancing healthcare by investing in early-stage life sciences technologies. The firm focuses on strengthening Pennsylvania's life sciences ecosystem and improving global healthcare outcomes. By providing early-stage capital and operational expertise, LSG Investments fosters company growth and job creation, bridging the gap between pre-seed and Series B funding.

SoftBank Vision Fund is a leading venture capital firm that believes in the transformative power of technology. The firm focuses on supporting a full-stack AI technology ecosystem, investing in hardware, infrastructure, and applications to drive innovation across various sectors. With a mission to back ambitious founders with scalable visions, SoftBank Vision Fund aims to create meaningful impact through long-term investments.

Pandect Bioventures is a venture capital firm focused on providing seed to Series A and later funding to early-stage biotech and pharma companies. The firm leverages its extensive ecosystem, including a 40,000 square foot incubator facility, to support entrepreneurs in achieving critical business milestones. Pandect Bioventures is committed to identifying transformational healthcare ideas at the earliest stage and building them into successful life science companies through strategic partnerships, financial and technical support, and access to state-of-the-art research facilities.

Osage University Partners (OUP) is a venture capital firm that specializes in investing in startups emerging from university research. With a focus on deep technology and science-based startups, OUP partners with over 100 universities and research institutions globally. The firm manages approximately $800 million and is committed to supporting groundbreaking scientific innovations through strategic investments and partnerships. Since its inception in 2009, OUP’s mission has been to foster deep partnerships with universities to invest in their spinouts, improve technology transfer effectiveness, and enhance research commercialization by connecting university startups to funding and recruitment opportunities.